Vir Biotechnology, Inc.
US ˙ NasdaqGS ˙ US92764N1028

SecurityVIR / Vir Biotechnology, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership2,098,476 shares
Latest Disclosed Value $ 18,802,345
Citadel Advisors Llc ownership in VIR / Vir Biotechnology, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 2,098,476 shares of Vir Biotechnology, Inc. (US:VIR) valued at $18,802,345 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 489,226 shares of Vir Biotechnology, Inc.. This represents a change in shares of 328.94% during the quarter. The current value of the position is $18,151,817 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (VIR) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 105,400 of underlying shares valued at $944,384 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VIR / Vir Biotechnology, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 2,098,476 1,609,250 328.94 18,802 537.36 0.0027
2026-02-17 2025-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 489,226 -309,808 -38.77 2,950 -35.34 0.0004
2025-11-14 2025-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 799,034 -2,665,883 -76.94 4,562 -73.88 0.0007
2025-08-14 2025-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 3,464,917 1,847,689 114.25 17,463 66.65 0.0030
2025-05-15 2025-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 1,617,228 1,345,964 496.18 10,480 426.32 0.0020
2025-02-14 2024-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 271,264 2,292 0.85 1,991 -1.14 0.0003
2024-11-14 2024-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 268,972 -481,015 -64.14 2,015 -69.82 0.0004
2024-08-14 2024-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 749,987 -2,657,845 -77.99 6,675 -80.67 0.0014
2024-05-15 2024-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 3,407,832 369,884 12.18 34,521 12.96 0.0067
2024-02-14 2023-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 3,037,948 2,954,409 3,536.56 30,562 3,808.06 0.0061
2023-11-14 2023-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 83,539 19,568 30.59 783 -50.16 0.0002
2023-08-14 2023-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 63,971 -267,822 -80.72 1,569 -79.68 0.0003
2023-05-15 2023-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 331,793 303,587 1,076.32 7,721 982.75 0.0017
2023-02-14 2022-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 28,206 -93,754 -76.87 714 -69.67 0.0002
2022-11-14 2022-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 121,960 121,960 2,351 0.0005
2022-05-16 2022-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 0 -590,876 -100.00 0 -100.00
2022-02-14 2021-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 590,876 451,777 324.79 24,740 308.72 0.0051
2021-11-15 2021-09-30 13F VIR BIOTECHNOLOGY Cmn 92764N102 139,099 108,342 352.25 6,053 316.30 0.0013
2021-08-16 2021-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 30,757 17,612 133.98 1,454 115.73 0.0003
2021-05-21 2021-03-31 13F/A-1 VIR BIOTECHNOLOGY COM 92764N102 13,145 -11,341 -46.32 674 2.74 0.0002
2021-05-17 2021-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 13,145 -11,341 674 0.0002
2021-02-16 2020-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 24,486 -46,153 -65.34 656 -72.95 0.0002
2020-11-16 2020-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 70,639 -93,890 -57.07 2,425 -64.03 0.0007
2020-08-14 2020-06-30 13F VIR BIOTECHNOLOGY Cmn 92764N102 164,529 164,529 6,741 0.0024
2020-05-15 2020-03-31 13F VIR BIOTECHNOLOGY Cmn 92764N102 0 -19,297 -100.00 0 -100.00
2020-02-14 2019-12-31 13F VIR BIOTECHNOLOGY Cmn 92764N102 19,297 19,297 243 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VIR BIOTECHNOLOGY COM Call 0 -100.00 0 n/a n/a n/a
2026-02-17 2025-12-31 13F VIR BIOTECHNOLOGY COM Call 40,800 120.54 246 134.29 n/a n/a n/a
2025-11-14 2025-09-30 13F VIR BIOTECHNOLOGY COM Call 18,500 -10.19 106 1.94 n/a n/a n/a
2025-08-14 2025-06-30 13F VIR BIOTECHNOLOGY COM Call 20,600 -28.72 104 -44.92 n/a n/a n/a
2025-05-15 2025-03-31 13F VIR BIOTECHNOLOGY COM Call 28,900 36.32 187 20.65 n/a n/a n/a
2025-02-14 2024-12-31 13F VIR BIOTECHNOLOGY COM Call 21,200 -32.48 156 -34.04 n/a n/a n/a
2024-11-14 2024-09-30 13F VIR BIOTECHNOLOGY COM Call 31,400 52.43 235 28.42 n/a n/a n/a
2024-08-14 2024-06-30 13F VIR BIOTECHNOLOGY COM Call 20,600 -26.69 183 -35.56 n/a n/a n/a
2024-05-15 2024-03-31 13F VIR BIOTECHNOLOGY COM Call 28,100 31.31 285 32.09 n/a n/a n/a
2024-02-14 2023-12-31 13F VIR BIOTECHNOLOGY COM Call 21,400 -45.13 215 -41.10 n/a n/a n/a
2023-11-14 2023-09-30 13F VIR BIOTECHNOLOGY COM Call 39,000 -12.36 365 -66.54 n/a n/a n/a
2023-08-14 2023-06-30 13F VIR BIOTECHNOLOGY COM Call 44,500 36.92 1,092 44.31 n/a n/a n/a
2023-05-15 2023-03-31 13F VIR BIOTECHNOLOGY COM Call 32,500 -33.94 756 -39.28 n/a n/a n/a
2023-02-14 2022-12-31 13F VIR BIOTECHNOLOGY COM Call 49,200 -6.46 1,245 22.78 n/a n/a n/a
2022-11-14 2022-09-30 13F VIR BIOTECHNOLOGY COM Call 52,600 -9.31 1,014 -31.35 n/a n/a n/a
2022-08-15 2022-06-30 13F VIR BIOTECHNOLOGY COM Call 58,000 -62.48 1,477 -62.85 n/a n/a n/a
2022-05-16 2022-03-31 13F VIR BIOTECHNOLOGY COM Call 154,600 -22.23 3,976 -52.23 n/a n/a n/a
2022-02-14 2021-12-31 13F VIR BIOTECHNOLOGY COM Call 198,800 135.27 8,324 126.38 n/a n/a n/a
2021-11-15 2021-09-30 13F VIR BIOTECHNOLOGY Cmn Call 84,500 19.01 3,677 9.53 n/a n/a n/a
2021-08-16 2021-06-30 13F VIR BIOTECHNOLOGY COM Call 71,000 -4.70 3,357 -12.12 n/a n/a n/a
2021-05-21 2021-03-31 13F/A VIR BIOTECHNOLOGY COM Call 74,500 23.14 3,820 135.80 n/a n/a n/a
2021-05-17 2021-03-31 13F VIR BIOTECHNOLOGY COM Call 74,500 3,820 n/a n/a n/a
2021-02-16 2020-12-31 13F VIR BIOTECHNOLOGY COM Call 60,500 166.52 1,620 107.96 n/a n/a n/a
2020-11-16 2020-09-30 13F VIR BIOTECHNOLOGY COM Call 22,700 -25.82 779 -37.88 n/a n/a n/a
2020-08-14 2020-06-30 13F VIR BIOTECHNOLOGY Cmn Call 30,600 1,254 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VIR BIOTECHNOLOGY COM Put 105,400 658.27 944 1,037.35 n/a n/a n/a
2026-02-17 2025-12-31 13F VIR BIOTECHNOLOGY COM Put 13,900 -12.58 84 -7.78 n/a n/a n/a
2025-11-14 2025-09-30 13F VIR BIOTECHNOLOGY COM Put 15,900 -44.60 91 -37.50 n/a n/a n/a
2025-08-14 2025-06-30 13F VIR BIOTECHNOLOGY COM Put 28,700 -7.12 145 -28.00 n/a n/a n/a
2025-05-15 2025-03-31 13F VIR BIOTECHNOLOGY COM Put 30,900 8.04 200 -4.31 n/a n/a n/a
2025-02-14 2024-12-31 13F VIR BIOTECHNOLOGY COM Put 28,600 197.92 210 194.37 n/a n/a n/a
2024-11-14 2024-09-30 13F VIR BIOTECHNOLOGY COM Put 9,600 -53.85 72 -61.62 n/a n/a n/a
2024-08-14 2024-06-30 13F VIR BIOTECHNOLOGY COM Put 20,800 -13.33 185 -23.87 n/a n/a n/a
2024-05-15 2024-03-31 13F VIR BIOTECHNOLOGY COM Put 24,000 37.93 243 38.86 n/a n/a n/a
2024-02-14 2023-12-31 13F VIR BIOTECHNOLOGY COM Put 17,400 -18.69 175 -12.50 n/a n/a n/a
2023-11-14 2023-09-30 13F VIR BIOTECHNOLOGY COM Put 21,400 -61.09 201 -85.17 n/a n/a n/a
2023-08-14 2023-06-30 13F VIR BIOTECHNOLOGY COM Put 55,000 97.13 1,349 107.86 n/a n/a n/a
2023-05-15 2023-03-31 13F VIR BIOTECHNOLOGY COM Put 27,900 372.88 649 335.57 n/a n/a n/a
2023-02-14 2022-12-31 13F VIR BIOTECHNOLOGY COM Put 5,900 -78.47 149 -71.78 n/a n/a n/a
2022-11-14 2022-09-30 13F VIR BIOTECHNOLOGY COM Put 27,400 -41.70 528 -55.89 n/a n/a n/a
2022-08-15 2022-06-30 13F VIR BIOTECHNOLOGY COM Put 47,000 -24.07 1,197 -24.81 n/a n/a n/a
2022-05-16 2022-03-31 13F VIR BIOTECHNOLOGY COM Put 61,900 -39.31 1,592 -62.73 n/a n/a n/a
2022-02-14 2021-12-31 13F VIR BIOTECHNOLOGY COM Put 102,000 50.44 4,271 44.73 n/a n/a n/a
2021-11-15 2021-09-30 13F VIR BIOTECHNOLOGY Cmn Put 67,800 23.50 2,951 13.67 n/a n/a n/a
2021-08-16 2021-06-30 13F VIR BIOTECHNOLOGY COM Put 54,900 -40.26 2,596 -44.91 n/a n/a n/a
2021-05-21 2021-03-31 13F/A VIR BIOTECHNOLOGY COM Put 91,900 156.70 4,712 391.35 n/a n/a n/a
2021-05-17 2021-03-31 13F VIR BIOTECHNOLOGY COM Put 91,900 4,712 n/a n/a n/a
2021-02-16 2020-12-31 13F VIR BIOTECHNOLOGY COM Put 35,800 41.50 959 10.36 n/a n/a n/a
2020-11-16 2020-09-30 13F VIR BIOTECHNOLOGY COM Put 25,300 24.63 869 4.45 n/a n/a n/a
2020-08-14 2020-06-30 13F VIR BIOTECHNOLOGY Cmn Put 20,300 832 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.